Eton Pharmaceuticals, Inc. (ETON) Cash Flow Statement
Eton Pharmaceuticals, Inc. (ETON) generated $15.1M of operating cash flow over the twelve months to 2026-06-30, spent $403000 on capital expenditure and had free cash flow of $14.7M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ETONEton Pharmaceuticals, Inc.Follow ETON — free
—
Price chart with a free account
- Market cap
- 1.4B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 11 days
| Line | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -18.0 | -22.3 | -4.7 | 4.8 | 6.8 | 1.0 | 10.5 | 15.1 | |
| Capital expenditure | 1.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.3 | -0.4 | |
| Free cash flow | -19.1 | -22.4 | -4.7 | 4.8 | 6.8 | 0.9 | 10.2 | 14.7 | |
| Stock-based compensation | 1.9 | 2.6 | 3.4 | 4.2 | 3.1 | 3.2 | 5.5 | — |
USD millions · SEC XBRL
Eton Pharmaceuticals, Inc. — questions
- What is Eton Pharmaceuticals, Inc.'s operating cash flow?
- $15.1M over the twelve months to 2026-06-30.
- How much does Eton Pharmaceuticals, Inc. spend on capital expenditure?
- $403000 over the twelve months to 2026-06-30.
- What is Eton Pharmaceuticals, Inc.'s free cash flow?
- $14.7M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Eton Pharmaceuticals, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.